Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
HJ Broxterman, KJ Gotink, HMW Verheul - Drug resistance updates, 2009 - Elsevier
Multiple molecular, cellular, micro-environmental and systemic causes of anticancer drug
resistance have been identified during the last 25 years. At the same time, genome-wide …
resistance have been identified during the last 25 years. At the same time, genome-wide …
[引用][C] Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
HJ Broxterman, KJ Gotink… - Drug …, 2009 - researchinformation.amsterdamumc …
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and
sunitinib — Amsterdam UMC research portal Skip to main navigation Skip to search Skip to …
sunitinib — Amsterdam UMC research portal Skip to main navigation Skip to search Skip to …
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib.
HJ Broxterman, KJ Gotink… - Drug Resistance Updates …, 2009 - europepmc.org
Multiple molecular, cellular, micro-environmental and systemic causes of anticancer drug
resistance have been identified during the last 25 years. At the same time, genome-wide …
resistance have been identified during the last 25 years. At the same time, genome-wide …
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
HJ Broxterman, KJ Gotink… - … updates: reviews and …, 2009 - pubmed.ncbi.nlm.nih.gov
Multiple molecular, cellular, micro-environmental and systemic causes of anticancer drug
resistance have been identified during the last 25 years. At the same time, genome-wide …
resistance have been identified during the last 25 years. At the same time, genome-wide …
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
HJ Broxterman, KJ Gotink, HMW Verheul - Drug Resistance Updates, 2009 - infona.pl
Multiple molecular, cellular, micro-environmental and systemic causes of anticancer drug
resistance have been identified during the last 25 years. At the same time, genome-wide …
resistance have been identified during the last 25 years. At the same time, genome-wide …